# OnCo record adg126 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/adg126/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "adg126" ;
  schema:name "ADG126"@en ;
  schema:description "ADG126 is an experimental monoclonal antibody from Adagene in phase 2 trials for hepatocellular carcinoma, aimed at CTLA-4."@en ;
  schema:url <https://onco.cc/drugs/adg126/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=ADG126> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:targets <https://onco.cc/targets/ctla4/> ;
  onco:companies <https://onco.cc/companies/sanofi/>, <https://onco.cc/companies/roche-genentech/> ;
  onco:trials <https://onco.cc/trials/nct04524871/>, <https://onco.cc/trials/nct05405595/>, <https://onco.cc/trials/nct05584670/> .